Several studies have reported that MIM-B expression is altered in a variety of tumors, such as bladder, prostate, colorectal, ovarian, breast, neck, and gastric tumors; basal cell carcinoma; and non-small cell lung cancer, as well as HCC [4–14]. Here, MTSS1 is linked to hepatocellular carcinoma.